公开(公告)号：US20240060998A1

公开(公告)日：2024-02-22

申请号：US18260914

申请日：2022-02-01

Applicant: Medtronic, Inc.

Inventor： Narendra K. Simha ,  Sinduja Thinamany ,  James W. Dawson

IPC: G01N33/86 ,  G01N1/28

CPC classification number: G01N33/86 ,  G01N1/28 ,  G01N2333/974 ,  G01N2333/8128 ,  G01N2800/226 ,  G01N2800/50

Abstract: A method for determining a patient's likelihood of experiencing a thromboembolic event when receiving an implantable blood contacting medical device. The method includes extracting a sample of blood from the patient. The sample of blood is exposed to a metal, metal alloy, or ceramic in a test tube. The sample of the blood is agitated in the test tube. A thromboembolic marker for the sample in the test tube is measured. If the thromboembolic marker for the sample in the test tube is higher than a predetermined thromboembolic marker threshold, it is determined that the patient is likely to experience the thromboembolic event when receiving the blood contacting implantable medical device.